viking oral glp 1 Therapeutics' weight-loss pill shows 'great outcome' in trial Side Effects Make Viking's Oral

This medical intervention not only suppresses hunger but also contributes to weight reduction and an improved body mass index (BMI)

is supported by the Ligue contre le Cancer (quipe labellise)

GLP-1 RAs reduce food intake and inhibit gastric emptying by activating GLP-1R+ cells in the nervous system, resulting in weight loss (41)

Modalit d'uso: Si consiglia l'assunzione di 2 capsule al giorno al mattino, oppure prima/durante gli sport anaerobici

Summary: GLP-1 receptor agonists are not licensed for NAFLD treatment in the UK but may reduce liver fat and improve metabolic parameters when prescribed for type 2 diabetes or weight management in eligible patients with concurrent liver disease

29 , 32563265.e5 (2019)